Preview

Трансплантология

Расширенный поиск

Статус питания больных муковисцидозом до и после трансплантации легких

https://doi.org/10.23873/2074-0506-2017-9-2-125-136

Полный текст:

Аннотация

В обзоре освещены ключевые особенности статуса питания больных муковисцидозом, современные подходы к мониторингу и коррекции нарушений алиментарного статуса пациентов до и после трансплантации легких (ТЛ).

Об авторах

М. Ш. Хубутия
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия

академик РАН, профессор, президент НИИ скорой помощи им. Н.В. Склифосовского, Москва, Россия



М. Е. Ильинский
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия


А. А. Рык
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия


Ю. Н. Лященко
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия


Список литературы

1. Cohen-Cymberknoh M., Shoseyov D., Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am. J. Respir. Crit. Care Med. 2011;183(11):1463–1471. PMID:21330455 DOI:10.1164/rccm.201009-1478CI

2. Li L., Somerset S. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig. Liver Dis. 2014;46(10):865–874. PMID:25053610 DOI:10.1016/j.dld.2014.06.011

3. Culhane S., George C., Pearo B., Spoede E. Malnutrition in cystic fibrosis: a review. Nutr. Clin. Pract. 2013;28(6):676–683. PMID:24170579 DOI:10.1177/0884533613507086

4. Corey M., McLaughlin F.J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J. Clin. Epidemiol. 1988;41(6):583–591. PMID:3260274

5. Stallings V.A., Stark L.J., Robinson K.A. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J. Am. Diet. Assoc. 2008;108(5):832–839. PMID:18442507 DOI:10.1016/j.jada.2008.02.020

6. Петрова Н.В., Гинтер Е.К. Молекулярно-генетические аспекты муковисцидоза. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 37–80.

7. Andersen D.H., Dorothy H. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathological study. Am. J. Dis. Child. 1938;56(2):344–399. DOI:10.1001/archpedi.1938.01980140114013

8. Stephenson A.L., Mannik L.A., Walsh S. et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am. J. Clin. Nutr. 2013;97(4):872–877.

9. Амелина Е.Л., Гембицкая Т.Е., Черменская А.Г. Особенности муковисцидоза взрослых. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 548–575.

10. Robinson P.J., Smith A.L., Sly P.D. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig. Dis. Sci. 1990;35(10):1299–1304. PM-ID:2120019

11. Perano S., Rayner C.K., Couper J. et al. Cystic fibrosis related diabetes – a new perspective on the optimal management of postprandial glycemia. J. Diabetes Complicat. 2014;28(6):904–911. PMID:25060530 DOI:10.1016/j.jdiacomp.2014.06.012

12. Debray D., Kelly D., Houwen R. et al. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J. Cyst. Fibros. 2011;10(Suppl 2):S29–S36. PMID:21658639 DOI:10.1016/S1569-1993(11)60006-4

13. Каширская Н.Ю. Поражение поджелудочной железы, изменения со стороны гепатобилиарной системы у больных муковисцидозом. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 295–345.

14. Moran A., Dunitz J., Nathan B. et al. Cystic fibrosisrelated diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32(9):1626– 1631. PMID:19542209 DOI:10.2337/dc09-0586

15. Waugh N., Royle P., Craigie I. et al. Screening for cystic fibrosis-related diabetes: a systematic review. Health Technol. Assess. 2012;16(24):iii–iv,1–179. PMID:22572153 DOI:10.3310/hta16240

16. Moran A., Pillay K., Becker D.J. ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis related diabetes in children and adolescents. Pediatr. Diabetes. 2014;15(Suppl 20):65–76. PMID:25182308 DOI:10.1111/pedi.12178

17. Moran A., Brunzell C., Cohen R.C. et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care. 2010;33(12):2697–2708. PMID:21115772 PMCID:PMC2992215 DOI:10.2337/dc10-1768

18. Colombo C., Battezzati P.M., Crosignani A. et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology. 2002;36(6):1374– 1382. PMID:12447862 DOI:10.1053/jhep.2002.37136

19. Lindblad A., Glaumann H., Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999;30(5):1151– 1158. PMID:10534335 DOI:10.1002/hep.510300527

20. Van Biervliet S., Van Biervliet J.P., Robberecht E., Christophe A. Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease. Clin. Chem. Lab. Med. 2010;48(12):1751– 1755. PMID:20961201 DOI:10.1515/CCLM.2010.336

21. Conway S.P., Morton A.M., Oldroyd B. et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax. 2000;55(9):798– 804. PMID:10950902

22. Gronowitz E., Lorentzon M., Ohlsson C. et al. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis. Br. J. Nutr. 2008;99(1):160– 167. PMID:17697399 DOI:10.1017/S000711450780105X

23. Yen E.H., Quinton H., Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J. Pediatr. 2013;162(3):530– 535. PMID:23062247 DOI:10.1016/j.jpeds.2012.08.040

24. Kerem E., Viviani L., Zolin A. et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry. Eur. Respir J. 2014;43(1):125–133. PMID:23598952 DOI:10.1183/09031936.00166412

25. Sinaasappel M., Stern M., Littlewood J. et al. Nutrition in patients with cystic fibrosis: a European Consensus. J. Cyst. Fibros. 2002;1(2):51–75. PM-ID:15463811

26. Smyth A.R., Bell S.C., Bojcin S. et al. European cystic fibrosis Society standards of care: best practice guidelines. J. Cyst. Fibros. 2014;13(Suppl 1):S23– S42. PMID:24856775 DOI:10.1016/j.jcf.2014.03.010

27. Turck D., Braegger C.P., Colombo C. et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin. Nutr. 2016;35(3):557–577. PMID:27068495 DOI:10.1016/j.clnu.2016.03.004

28. Thomson M.A., Bucolo S., Quirk P., Shepherd R.W. Measured versus predicted resting energy expenditure in infants: a need for reappraisal. J. Pediatr. 1995;126(1):21–27. PMID:7815217

29. Thomson M.A., Wilmott R.W., Wainwright C. et al. Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. J. Pediatr. 1996;129(3):367–373. PMID:8804325

30. Wood L.G., Gibson P.G., Garg M.L. Circulating markers to assess nutritional therapy in cystic fibrosis. Clin. Chim. Acta. 2005;353(1–2):13–29. PMID:15698587 DOI:10.1016/j.cccn.2004.11.002

31. Cystic Fibrosis Trust. Nutritional management of cystic fibrosis. London, UK, 2002.

32. Powers S.W., Mitchell M.J., Patton S.R. et al. Mealtime behaviors in families of infants and toddlers with cystic fibrosis. J. Cyst. Fibros. 2005;4(3):175– 182. PMID:15982934 DOI:10.1016/j.jcf.2005.05.015

33. Gaskin K. J. Nutritional care in children with cystic fibrosis: are our patients becoming better? Eur. J. Clin. Nutr. 2013;67(5):558–564. PMID:23462946 DOI:10.1038/ejcn.2013.20

34. Olveira G., Olveira C., Acosta E. et al. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis. Arch. Bronconeumol. 2010;46(2):70– 77. PMID:20045240 DOI:10.1016/j.arbres.2009.11.001

35. Keen C., Olin A.C., Eriksson S. et al. Supplementation with fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 2010;50(5):537–544. PMID:20639712 DOI:10.1097/MPG.0b013e3181b47967

36. Oliver C., Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst. Rev. 2013;11:CD002201. PMID:24282091 DOI:10.1002/14651858.CD002201.pub4

37. Sermet-Gaudelus I., Bianchi M.L., Garabédian M. et al. European cystic fibrosis bone mineralisation guidelines. J. Cyst. Fibros. 2011;10(Suppl 2):S16–S23. PMID:21658635 DOI:10.1016/S1569-1993(11)60004-0

38. Cystic Fibrosis Trust. Bone mineralisation in cystic fibrosis. London, UK, 2007.

39. Chinuck R., Dewar J., Baldwin D.R., Hendron E. Appetite stimulants for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;7:CD008190. PMID:25064192 DOI:10.1002/14651858.CD008190.pub2

40. Bruzzese E., Raia V., Gaudiello G. et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment. Pharmacol. Ther. 2004;20(7):813–819. PMID:15379842 DOI:10.1111/j.1365-2036.2004.02174.x

41. Bruzzese E., Raia V., Spagnuolo M.I. et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin. Nutr. 2007;26(3):322–328. PMID:17360077 DOI:10.1016/j.clnu.2007.01.004

42. Kindstedt-Arfwidson K., Strandvik B. Food intake in patients with cystic fibrosis on an ordinary diet. Scand. J. Gastroenterol. Suppl. 1988;143:160–162. PMID:3164504

43. Smith C., Winn A., Seddon P., Ranganathan S. A fat lot of good: balance and trends in fat intake in children with cystic fibrosis. J. Cyst. Fibros. 2012;11(2):154–157. PMID:22119390 DOI:10.1016/j.jcf.2011.10.007

44. Woestenenk J.W., Castelijns S.J., van der Ent C.K., Houwen R.H. Dietary intake in children and adolescents with cystic fibrosis. Clin Nutr. 2014;33(3):528– 532. PMID: 23920501 DOI: 10.1016/j.clnu.2013.07.011

45. Cystic Fibrosis Foundation Patient Registry. Annual Data 2012. Bethesda, Maryland, 2013.

46. Steinkamp G., Demmelmair H., Rühl-Bagheri I. et al. Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. J. Pediatr. Gastroenterol. Nutr. 2000;31(4):418–423. PMID:11045840

47. Rettammel A.L., Marcus M.S., Farrell P.M. et al. Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum li pids in patients with cystic fibrosis. J. Am. Diet. Assoc. 1995;95(4):454–459. PMID:7699188 DOI: 10.1016/S0002-8223(95)00121-2

48. Alison J.A., Donnelly P.M., Lennon M. et al. The effect of a comprehensive, intensive inpatient treatment program on lung function and exercise capacity in patients with cystic fibrosis. Phys. Ther. 1994;74(6):583–591. PMID:8197244

49. Heijerman H.G. Chronic obstructive lung disease and respiratory muscle function: the role of nutrition and exercise training in cystic fibrosis. Respir. Med. 1993;87(Suppl. B):49–51. PMID:8234970

50. Williams S.G., Ashworth F., McAlweenie A. et al. Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis. Gut. 1999;44(1):87–90. PMID:9862831

51. Rosenfeld M., Casey S., Pepe M., Ramsey B.W. Nutritional effects of longterm gastrostomy feedings in children with cystic fibrosis. J. Am. Diet. Assoc. 1999;99(2): 191– 194. PMID:9972186 DOI:10.1016/S0002-8223(99)00046-2

52. Allen E.D., Mick A.B., Nicol J., McCoy K.S. Prolonged parenteral nutrition for cystic fibrosis patients. Nutr. Clin. Pract.1995;10(2):73–79. PMID:7731428 DOI:10.1177/011542659501000273

53. Авдеев С.Н. Трансплантация легких при муковисцидозе. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 595–611.

54. Spahr J.E., Love R.B., Francois M. et al. Lung transplantation for cystic fibrosis: current concepts and one center's experience . J. Cyst. Fibros. 2007;6(5):334–350. PMID:17418647 DOI:10.1016/j.jcf.2006.12.010

55. Stehlik J., Edwards L.B., Kucheryavaya A.Y. et al. The Registry of the International Society for Heart and Lung transplantation: 29th adult lung and heart-lung transplant report – 2012. J. Heart Lung. Transplant. 2012;31(10):1073–1086. PMID:22975095DOI:10.1016/j.healun.2012.08.002

56. Lederer D.J., Wilt J.S., D'Ovidio F. et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am. J. Respir. Crit. Care Med. 2009;180(9):887– 895. PMID:19608717 DOI:10.1164/rccm.200903-0425OC

57. Регистр больных муковисцидозом в Российской Федерации. 2011 г. Пульмонология. 2014; Прил. Режим доступа: http://mukoviscidoz.org/doc/registr/Registr_end_2011.pdf

58. Egan J.J., Woodcock A.A., Webb A.K. Management of cystic fibrosis before and after lung transplantation. J. R. Soc. Med.1997;90(Suppl 31):47–58. PMID:9204012

59. Elborn J.S., Jagoe T., Shale D.J. Metabolic and respiratory consequences of a glucose load in hypoxic patients with cystic fibrosis. Ulster Med. 1992;61(2):188– 192. PMID:1481313

60. Hirche T.O., Knoop C., Hebestreit H. et al. Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis. Pulm. Med. 2014;2014:621342. PMID:24800072 DOI:10.1155/2014/621342

61. Tynan C., Hasse J.M. Current nutrition practices in adult lung transplantation. Nutr. Clin. Pract. 2004;19(6):587–596. PMID:16215158 DOI:10.1177/0115426504019006587

62. Kalnins D., Wilschanski M. Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies. Drug. Des. Devel. Ther. 2012;6:151–161. PMID:22787388 DOI:10.2147/DDDT.S9258

63. Ho T., Gupta S., Brotherwood M. et al. Increased serum vitamin A and e levels after lung transplantation. Transplantation. 2011;92(5):601–606. PMID:21841542 DOI:10.1097/TP.0b013e31822790e3

64. Stephenson A., Brotherwood M., Robert R. et al. Increased vitamin A and E levels in adult cystic fibrosis patients after lung transplantation. Transplantation. 2005;79(5):613– 615. PMID:15753854

65. Hadjiliadis D., Madill J., Chaparro C. et al. Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation. Clinical Transplantation. 2005;19(6):773– 778. PMID:16313324 DOI:10.1111/j.1399-0012.2005.00420.x

66. Gottlieb J., Ballmann M., von Mallinckrodt C. et al. Lung transplantation in cystic fibrosis - a position paper. Pneumologie. 2009;63(8):451–460. PMID:19670104 DOI:10.1055/s-0029-1214821

67. Gilljam M., Chaparro C., Tullis E. et al. GI complications after lung transplantation in patients with cystic fibrosis. Chest. 2003;123(1):37–41. PMID:12527600

68. Atkins B.Z., Petersen R.P., Daneshmand M.A. et al. Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation. Ann. Thorac. Surg. 2010;90(5):1622–1628. PMID:20971276 DOI:10.1016/j.athoracsur.2010.06.089

69. Dellon E.S., Morgan D.R., Mohanty S.P. et al. High incidence of gastric bezoars in cystic fibrosis patients after lung transplantation. Transplantation. 2006;81(8):1141–1146. PMID:16641599 DOI:10.1097/01.tp.0000205813.54136.85

70. Mendez B.M., Davis C.S., Weber C. et al. Gastroesophageal reflux disease in lung transplant patients with cystic fibrosis. Am. J. Surg. 2012;204(5):e21– e26. PMID:22921151 DOI:10.1016/j.amjsurg.2012.07.019

71. Quon B.S., Mayer-Hamblett N., Aitken M.L., Goss C.H. Risk of post lung transplant renal dysfunction in adults with cystic fibrosis. Chest. 2012;142(1):185– 191. PMID:22222189 DOI:10.1378/chest.11-1926

72. Outbreak of Salmonella serotype Javinia infections. Orlando, Florida, June 2002. MMWR Morb Mortal Wkly Rep. 2002;51(31):683–684. PMID:12233909

73. Goulet V., Hebert M., Hedberg C. et al. Incidence of listeriosis and relate d mortality among groups at risk of acquiring listeriosis. Clin. Infect. Dis. 2012;54(5):652–660. PMID:22157172 DOI:10.1093/cid/cir902

74. Mathur S., Hornblower E., Levy R.D. Exercise training before and after lung transplantation. Phys. Sportsmed. 2009;37(3):78–87. PMID:20048531 DOI:10.3810/psm.2009.10.1732


Для цитирования:


Хубутия М.Ш., Ильинский М.Е., Рык А.А., Лященко Ю.Н. Статус питания больных муковисцидозом до и после трансплантации легких. Трансплантология. 2017;9(2):125-136. https://doi.org/10.23873/2074-0506-2017-9-2-125-136

For citation:


Khubutiya M.S., Il'inskiy M.E., Ryk A.A., Lyashchenko Y.N. Nutritional status in patients with cystic fi brosis before and after lung transplantation. Transplantologiya. The Russian Journal of Transplantation. 2017;9(2):125-136. (In Russ.) https://doi.org/10.23873/2074-0506-2017-9-2-125-136

Просмотров: 232


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2074-0506 (Print)
ISSN 2542-0909 (Online)